Evidence map›Paper›PMID 36283476›Full record

ArticleThe Journal of hospital infection2023

Antimicrobial overuse in COVID-19 - reasons to remain vigilant as we approach the winter 'twindemic'.

J Lowry, N McEvoy, K O'Connell, K Burns, B Dinesh, S O'Donnell, G F Curley, F Fitzpatrick

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of hospital infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

J LowryDepartment of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland. Electronic address: jessica.lowry2@outlook.com.
N McEvoyDepartment of Critical Care, Beaumont Hospital, Dublin, Ireland; Department of Critical Care, The Royal College of Surgeons in Ireland, Dublin, Ireland.
K O'ConnellDepartment of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland; Department of Clinical Microbiology, The Royal College of Surgeons in Ireland, Dublin, Ireland.
K BurnsDepartment of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland; Department of Clinical Microbiology, The Royal College of Surgeons in Ireland, Dublin, Ireland.
B DineshDepartment of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland; Department of Clinical Microbiology, The Royal College of Surgeons in Ireland, Dublin, Ireland.
S O'DonnellDepartment of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland; Department of Clinical Microbiology, The Royal College of Surgeons in Ireland, Dublin, Ireland.
G F CurleyDepartment of Critical Care, Beaumont Hospital, Dublin, Ireland; Department of Critical Care, The Royal College of Surgeons in Ireland, Dublin, Ireland.
F FitzpatrickDepartment of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland; Department of Clinical Microbiology, The Royal College of Surgeons in Ireland, Dublin, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsCOVID-19HumansSeasonsAnti-Infective Agents

Identifiers

PMID36283476
PMCPMC9595493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.